Stock Events

Stock Events

Bioter SA 

€0.2060
2
+€0.02+10.16%Wednesday 08:59

Statistics

Day High
0.206
Day Low
0.206
52W High
0.206
52W Low
0.206
Volume
6,750
Avg. Volume
0
Mkt Cap
3.62M
P/E Ratio
0.61
Dividend Yield
-
Dividend
-

Dividends

0%Dividend Yield
Aug 2006
€0.08
Aug 2005
€0.24
Aug 2004
€0.16
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Financials

14,008.48%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
389,000Revenue
54.49MNet Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Merck
MRK
Mkt Cap368.89B
Merck & Co., Inc. is a global healthcare company that develops pharmaceutical products, competing directly in the healthcare sector with Bioter SA.
Pfizer
PFE
Mkt Cap173.95B
Pfizer Inc. is involved in the discovery, development, and manufacture of healthcare products similar to Bioter SA.
Johnson & Johnson
JNJ
Mkt Cap657.68B
Johnson & Johnson is a comprehensive healthcare firm that manufactures pharmaceuticals that directly compete with Bioter SA's product offerings.
GSK
GSK
Mkt Cap99.19B
GlaxoSmithKline plc engages in the creation and marketing of pharmaceutical and healthcare products, competing in the same markets as Bioter SA.
Novartis
NVS
Mkt Cap303.67B
Novartis AG is known for innovative medicines and directly competes with Bioter SA in various therapeutic areas.
Abbvie
ABBV
Mkt Cap521.11B
AbbVie Inc. operates in the pharmaceutical industry, developing products that compete in the same categories as Bioter SA.
AMGEN
AMGN
Mkt Cap251.94B
Amgen Inc. focuses on human therapeutics and competes in the biotechnology industry alongside Bioter SA.
Sanofi
SNY
Mkt Cap106.24B
Sanofi engages in the pharmaceuticals business globally, offering products that compete with those of Bioter SA.
Bristol-Myers Squibb
BMY
Mkt Cap127.71B
Bristol-Myers Squibb Company offers biopharmaceutical products that compete with Bioter SA in multiple therapeutic areas.
Roche
RHHBY
Mkt Cap334.28B
Roche Holding AG is a major player in diagnostics and pharmaceuticals, competing with Bioter SA in the healthcare market.

About

Bioter S.A. functions as an engineering and construction company, with operations extending throughout Greece and globally. Its diverse project portfolio includes the development of critical infrastructure such as roads, ports, airports, and specialized facilities for industrial, energy, and defense sectors, alongside complex electromechanical and communication systems. The firm also engages in private construction, delivering commercial properties like office complexes, banking premises, and automotive service centers. Founded in 1961, Bioter S.A. has its headquarters in Athens, Greece.
Show More
CEO
Ioannis Konstantinopoulos
Employees
5
Country
Other
ISIN
GRS135003002

Listings

LSE
GB
0P0F.LSE
AT
GR
BIOT.AT

0 Comments

Share your thoughts

FAQs

What is Bioter SA stock price today?▼
The current price of BIOT.AT is €0.21 EUR — it has increased by +10.16% in the past 24 hours. Watch Bioter SA stock price performance more closely on the chart.
What is Bioter SA stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Athens Exchange exchange Bioter SA stocks are traded under the ticker BIOT.AT.
What is Bioter SA market cap?▼
Today Bioter SA has the market capitalization of 3.62M
What is Bioter SA revenue for the last year?▼
Bioter SA revenue for the last year amounts to 389,000 EUR.
What is Bioter SA net income for the last year?▼
BIOT.AT net income for the last year is 54.49M EUR.
Does Bioter SA pay dividends?▼
Yes, BIOT.AT dividends are paid annual. The last dividend per share was 0.08 . As of today, Dividend Yield (FWD)% is 0%.
How many employees does Bioter SA have?▼
As of November 2, 2026, the company has 5 employees.
In which sector is Bioter SA located?▼
Bioter SA operates in the Manufacturing sector.
When did Bioter SA complete a stock split?▼
The last stock split for Bioter SA was on August 2, 2010 with a ratio of 0.25:1.
Where is Bioter SA headquartered?▼
Bioter SA is headquartered in Athens, Other.